Maintenance immunotherapy in patients with metastatic breast cancer (MBC) who have a clinical benefit with chemotherapy. Long-term follow-up of a phase II study.

被引：1
|
作者：
Recchia, Francesco [1 ]
机构：
[1] Oncol Osped Civile, Avezzano, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e13068
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13068
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Maintenance immunotherapy in patients with advanced cancer (AC): Long term follow-up of a phase II study.
    Recchia, Francesco
    Candeloro, Giampiero
    Necozione, Stefano
    Bratta, Massimo
    Rosselli, Michele
    Rea, Silvio
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] Maintenance immunotherapy in estrogen receptor negative (ER-) locally advanced (LA) and/or metastatic breast cancer (MBC). Long-term follow-up of a phase II study
    Recchia, F.
    Candeloro, G.
    Rea, S.
    [J]. CANCER RESEARCH, 2017, 77
  • [3] Maintenance immunotherapy in stage IV cancer patients who have a clinical benefit from chemotherapy.
    Recchia, Francesco
    Candeloro, Giampiero
    Rea, Silvio
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [4] Maintenance immunotherapy in recurrent ovarian cancer: Long term follow-up of a phase II study
    Recchia, Francesco
    Di Orio, Ferdinando
    Candeloro, Giampiero
    Guerriero, Gabriele
    Piazze, Juan
    Rea, Silvio
    [J]. GYNECOLOGIC ONCOLOGY, 2010, 116 (02) : 202 - 207
  • [5] Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer
    Greenberg, PAC
    Hortobagyi, GN
    Smith, TL
    Ziegler, LD
    Frye, DK
    Buzdar, AU
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (08) : 2197 - 2205
  • [6] Beta-interferon, retinoids and tamoxifen in metastatic breast cancer: Long-term follow-up of a phase II study
    Recchia, Francesco
    Sica, Gigliola
    Candeloro, Giampiero
    Necozione, Stefano
    Bisegna, Roberta
    Bratta, Massimo
    Rea, Silvio
    [J]. ONCOLOGY REPORTS, 2009, 21 (04) : 1011 - 1016
  • [7] Long-term follow-up of a multicenter phase II study of chemo-immunotherapy in the treatment of metastatic colorectal cancer (MCC).
    Recchia, F.
    Candeloro, G.
    Necozione, S.
    Lippe, P.
    Desideri, G.
    Rea, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [8] Long-term follow-up of advanced gastric cancer patients who achieved a pathologic complete response with neoadjuvant chemotherapy.
    Cho, Haruhiko
    Yoshikawa, Takaki
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [9] Total estrogen blockade and chemotherapy in high-risk premenopausal early breast cancer (BC): Long-term follow-up of a phase II study.
    Recchia, Francesco
    Candeloro, Giampiero
    Cesta, Alisia
    Necozione, Stefano
    Rea, Silvio
    Bratta, Massimo
    Hoo, William Soo
    Cantor, Thomas
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] Maintenance hormonal and immunotherapy in metastatic breast cancer with a clinical benefit from anthracycline-paclitaxel based induction chemotherapy.
    Recchia, F.
    Candeloro, G.
    Necozione, S.
    Rea, S.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S275 - S275
12345